Generic drug company Mylan raised its bid for a second time for Perrigo on Wednesday, offering $35.6 billion for the over-the-counter giant.

Mylan, which itself is fending off a takeover bid from generics giant Teva, offered $75 in cash and 2.3 Mylan shares for each Perrigo share. Mylan last Friday offered $32.6 billion for Perrigo, only to see that quickly rejected as too low.